BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 24, 2020
View Archived Issues
Janpix describes small-molecule monovalent STAT3 and STAT5 protein degraders
Read More
CStone Pharmaceuticals presents data on the CDK4/6 inhibitor CS-3002
Read More
Phase II/III study begins with mavrilimumab in severe COVID-19 pneumonia and hyperinflammation
Read More
Bayer initiates first-in-human study of BAY-2701439 in advanced HER2-expressing cancers
Read More
M-6223 studied in first-in-human trial for metastatic or locally advanced solid unresectable tumors
Read More
Akeso begins phase II study of AK-104 in recurrent or metastatic cervical cancer
Read More
Fe-isty cancer cells flourish in hostile subarachnoid space
Read More
DS-6157a demonstrates promising efficacy in preclinical models of GIST
Read More
Novartis reports first-in-human data for BLZ-945
Read More
Regeneron reports preclinical data on 89Zr-labeled REGN-5054 antibody for CD8+ T-cell monitoring
Read More
Array BioPharma identifies new protein kinase inhibitors
Read More
Patient enrollment begins in Ampion COVID-19 program
Read More
In vivo studies show potent reversal of anticoagulation with VMX-COO1
Read More
Topline phase III data for favipiravir in patients with COVID-19
Read More
Promising preclinical data for NurOwn-derived exosome-based therapy for COVID-19 ARDS
Read More
Kaleido Biosciences initiates second study of KB-109 in outpatients with COVID-19
Read More
FDA lifts clinical hold on all development of seladelpar
Read More
Cybrexa Therapeutics details development of peptide-drug conjugate CBX-13 for solid tumors
Read More
Sareum reports findings with TYK2/JAK1 inhibitors in disease model of lupus
Read More
Exonbio launches SARS-CoV-2 monoclonal antibodies for research
Read More
